Lucira Health Inc expected to post a loss of 38 cents a share - Earnings Preview

Lucira Health

11/11/2022 11:38

* Lucira Health Inc  LHDX.OQ   LHDX.O  is expected to show a
rise
in quarterly revenue when it reports  results on November 14. 
    * The Emeryville California-based  company is expected to
report 
a 119.0% increase in revenue to $32.79 million from $14.98
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Lucira Health Inc
is for
a loss of 38 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lucira
Health Inc
is $3.5​, above​ its last closing price of $0.70. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022              -0.34      -0.45     Missed  -32.4
 Mar. 31 2022  -0.09       -0.08      0.40      Beat    600
 Dec. 31 2021  -0.55       -0.55      0.01      Beat    101.8​
 Sep. 30 2021  -0.52       -0.51      -0.47     Beat    8.4
 ​​Jun.        -0.32       -0.32      -0.38     Missed  -18.7
 30 2021                                                
 Mar. 31 2021  -0.33       -0.33      -0.54     Missed  -63.6​
 This summary was machine generated November 11 at 11:38 GMT. 
All figures in US dollars  unless otherwise stated